# Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients

> **NCT00274001** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 158 (actual)

## Conditions studied

- HIV Infections
- Quality of Life

## Interventions

- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00274001
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2004-03
- **Final completion:** 2004-03
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274001, "Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00274001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*